Oncologist-approved cancer information from the American Society of Clinical Oncology

Gastrointestinal Stromal Tumor (GIST)

News and highlights from ASCO Annual Meetings.


Category :
Year :
 
 
New Drug Shows Promise in Treating Imatinib-Resistant GIST
June 6, 2004

A new drug called SU11248 shrinks or slows the progression of cancer in patients with gastrointestinal stromal tumor (GIST) whose tumors have stopped responding to the standard treatment of imatinib (Gleevec). However, imatinib eventually stops working in about half of all patients, and the cancer progresses.

<<Previous | Page 1 of 1 | Next>>